The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant

Suraj Kapa; Mathew D. Hutchinson

doi:10.1016/j.ccep.2012.02.006

The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant

Suraj Kapa, Mathew D. Hutchinson

Cardiovascular Medicine

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Most patients referred for ventricular tachycardia (VT) ablation have already suffered multiple therapies for recurrent VT, typically in the form of implantable cardioverter defibrillator (ICD) shocks. Recent landmark trials have looked at these populations and suggest potential usefulness of early, preventive ablation of VT in patients with ischemic cardiomyopathy. In this review the potential role of early VT ablation in patients with ischemic cardiomyopathy, current controversies regarding VT ablation in this population, and ongoing and future research that may further inform clinical decision making regarding optimal timing of ablation in these patients are discussed.

Original language	English (US)
Pages (from-to)	189-198
Number of pages	10
Journal	Cardiac Electrophysiology Clinics
Volume	4
Issue number	2
DOIs	https://doi.org/10.1016/j.ccep.2012.02.006
State	Published - Jun 1 2012

Keywords

Ablation
Heart failure
Myocardial infarction
Ventricular tachycardia

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1016/j.ccep.2012.02.006

Cite this

The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant. / Kapa, Suraj; Hutchinson, Mathew D.
In: Cardiac Electrophysiology Clinics, Vol. 4, No. 2, 01.06.2012, p. 189-198.

Research output: Contribution to journal › Review article › peer-review

@article{6c989a5afdc546e190da9db527ccda1b,

title = "The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant",

abstract = "Most patients referred for ventricular tachycardia (VT) ablation have already suffered multiple therapies for recurrent VT, typically in the form of implantable cardioverter defibrillator (ICD) shocks. Recent landmark trials have looked at these populations and suggest potential usefulness of early, preventive ablation of VT in patients with ischemic cardiomyopathy. In this review the potential role of early VT ablation in patients with ischemic cardiomyopathy, current controversies regarding VT ablation in this population, and ongoing and future research that may further inform clinical decision making regarding optimal timing of ablation in these patients are discussed.",

keywords = "Ablation, Heart failure, Myocardial infarction, Ventricular tachycardia",

author = "Suraj Kapa and Hutchinson, {Mathew D.}",

year = "2012",

month = jun,

day = "1",

doi = "10.1016/j.ccep.2012.02.006",

language = "English (US)",

volume = "4",

pages = "189--198",

journal = "Cardiac Electrophysiology Clinics",

issn = "1877-9182",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant

AU - Kapa, Suraj

AU - Hutchinson, Mathew D.

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Most patients referred for ventricular tachycardia (VT) ablation have already suffered multiple therapies for recurrent VT, typically in the form of implantable cardioverter defibrillator (ICD) shocks. Recent landmark trials have looked at these populations and suggest potential usefulness of early, preventive ablation of VT in patients with ischemic cardiomyopathy. In this review the potential role of early VT ablation in patients with ischemic cardiomyopathy, current controversies regarding VT ablation in this population, and ongoing and future research that may further inform clinical decision making regarding optimal timing of ablation in these patients are discussed.

AB - Most patients referred for ventricular tachycardia (VT) ablation have already suffered multiple therapies for recurrent VT, typically in the form of implantable cardioverter defibrillator (ICD) shocks. Recent landmark trials have looked at these populations and suggest potential usefulness of early, preventive ablation of VT in patients with ischemic cardiomyopathy. In this review the potential role of early VT ablation in patients with ischemic cardiomyopathy, current controversies regarding VT ablation in this population, and ongoing and future research that may further inform clinical decision making regarding optimal timing of ablation in these patients are discussed.

KW - Ablation

KW - Heart failure

KW - Myocardial infarction

KW - Ventricular tachycardia

UR - http://www.scopus.com/inward/record.url?scp=84860594707&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860594707&partnerID=8YFLogxK

U2 - 10.1016/j.ccep.2012.02.006

DO - 10.1016/j.ccep.2012.02.006

M3 - Review article

AN - SCOPUS:84860594707

SN - 1877-9182

VL - 4

SP - 189

EP - 198

JO - Cardiac Electrophysiology Clinics

JF - Cardiac Electrophysiology Clinics

IS - 2

ER -

The Role of Preventive Ablation of Ventricular Tachycardia in the Patient with Coronary Artery Disease, Reduced Left Ventricular Function, and a New Implantable Cardioverter Defibrillator Implant

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this